SVF ENDURANCE (CAYMAN) LTD sold 1.6% of their position (251.36K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.54M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/14/2025ACC: 0001493152-25-018021
10% Owner
Since Oct 2019
-251.36K
Net shares
Net seller
$1.54M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
251.36K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−249.06K
Price / share
$6.14
Trade value
$1.53M
% of position
1.6%
10/9/2025
15.62M→15.37M
Common Stock
Indirect
Shares
−2.30K
Price / share
$6.08
Trade value
$13.97K
% of position
0.0%
10/10/2025
15.37M→15.37M
Total
Net shares
−251.36K
Net value
-$1.54M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/9/2025 | S · Sale | −249.06K | $6.14 | $1.53M | 1.6% | 15.62M | 15.37M |
| Common Stock Indirect | 10/10/2025 | S · Sale | −2.30K | $6.08 | $13.97K | 0.0% | 15.37M | 15.37M |
| Total | −251.36K | -$1.54M | ||||||
Derivative Transactions0
No derivative transactions reported